Back to results
US 2026/0008748 A1Published application
Compounds with biguanidyl radical and uses thereof
AssigneesInstitut Curie, Institut National de la Sante et de la Recherche Medicale, Centre National De La Recherche Scientifique
InventorsTATIANA CAÑEQUE, SEBASTIAN MÜLLER, RAPHAËL RODRIGUEZ
Life of this patent
Estimating the term…
Abstract
The present invention relates to new compounds of formula (I), and their uses.
Claims12
A compound of formula (I)
- wherein
- R1 is selected from the group consisting of a C1-C6 alkyl, —(CH2)a—C≡CH, —(CH2)b—P+Ph3, a C3-C10 cycloalkyl, a C3-C10 cycloheteroalkyl, a C6-C12 aryl, and a C5-C12 heteroaryl, with “a” being an integer selected from 1 to 6 and “b” being an integer selected from 5 to 11 said alkyl, cycloalkyl, cycloheteroalkyl, aryl or heteroaryl being optionally substituted by a R group or a R′ group;
- and
- R2 is selected from the group consisting of
- —(CH2)a—C≡CH, with “d” being an integer selected from 1 to 6;
- and
- —(CH2)e—CH═CH2 with “e” being an integer selected from 2 to 6;
- or
- R1 is selected from the group consisting of H, a C1-C6 alkyl, —(CH2)a-C≡CH, —(CH2)b—P+Ph3, a C3-C10 cycloalkyl, a C3-C10 cycloheteroalkyl, a C6-C12 aryl, and a C5-C12 heteroaryl, with “a” being an integer selected from 1 to 6 and “b” being an integer selected from 5 to 11, said alkyl, cycloalkyl, cycloheteroalkyl, aryl or heteroaryl being optionally substituted by a R group or a R′ group;
- R2 is selected from the group consisting of
- —(CH2)f—CR4═CH—CH═CR5—(CH2)g—R3 with R4 and R5 being H, a R group or forming together a six-member ring, optionally substituted by one or two R′ groups or fused with a cycloalkyl, an aryl, a cycloheteroalkyl or a heteroaryl having 3 to 6 members, “f” and “g” being an integer independently selected from 1 to 3;
- —(CH2)f—C≡C—C≡C—(CH2)g—R3, with “f” and “g” being an integer independently selected from 1 to 3;
- —(CH2)i—R3, with “i” being an integer selected from 7 to 9;
- —(CH2)j—CH[(CH2)k—P+Ph3]—(CH2)l—R3 with “j” and “l” being integer independently selected from 1 to 6, and “k” being an integer selected from 1 to 6;
- —(CH2)m-cyclobutanyl-(CH2)n—R3 with “m” and “n” being an integer independently selected from 1 to 3;
- and
- —(CH2)p—CHR6—CH═CH—CHR7—(CH2)q—R3 with R6 and R7 being H, a R group or forming together a 4-6 member ring, optionally substituted by one or two R′ groups or fused with a cycloalkyl, an aryl, a cycloheteroalkyl or a heteroaryl having 3 to 6 members, “p” and “q” being an integer independently selected from 1 to 3;
- and
- R3 is
- with R8 selected from the group consisting of H, a C1-C6 alkyl, —(CH2)a—C≡CH, —(CH2)b—P+Ph3, a C3-C10 cycloalkyl, a C3-C10 cycloheteroalkyl, a C6-C12 aryl, and a C5-C12 heteroaryl, with “a” being an integer selected from 1 to 6 and “b” being an integer selected from 5 to 11 said alkyl, cycloalkyl, cycloheteroalkyl, aryl or heteroaryl being optionally substituted by a R group or a R′ group;
- wherein
- R is selected from the group consisting of a C1-C6 alkyl, a C1-C6 alkyloxy, a C1-C6 halogenoalkyl, a C3-C10 cycloalkyl, a C3-C10 cycloheteroalkyl, a C6-C12 aryl, and a C5-C12 heteroaryl, the group being optionally substituted by a group R′,
- R′ is selected from the group consisting of a C1-C6 alkyl, a C1-C6 alkyloxy, a C1-C6 thioalkyl, a halogen, a C1-C6 halogenoalkyl, a hydroxyl (—OH), a cyano (—CN), a nitro, an amino (—NH2), a carboxyl (—COOH), a phosphate (PO4−), an amide (—CONH2), —COOR″, —NHR″, —NR″R″′, —COR″, —CONHR″, —NHCOR″, —NHSO2R″, —SOR″, —SO2R″, —SONR″R″′, —SO2NR″R′, a C3-C10 cycloalkyl, a C3-C10 cycloheteroalkyl, a C6-C12 aryl, and a C5-C12 heteroaryl, said cycloalkyl, cycloheteroalkyl, aryl or heteroaryl being optionally substituted by a halogen, a hydroxyl, a cyano, a nitro, an amino, or a C1-C3 alkoxy, with R″ and R′″ being H or a C1-C6 alkyl;
- or a pharmaceutically acceptable salt thereof.
21 more elements
Dependencies are inferred from the claim text.